Clinical Trials on Hyper-low-density Lipoprotein (LDL) Cholesterolemia in United Kingdom
Total 7 results
-
LIB Therapeutics LLCMedpace, Inc.Active, not recruitingCardiovascular Diseases | Hyper-LDL-cholesterolemiaUnited States
-
University of Nevada, Las VegasUniversity of Oklahoma; Oklahoma State UniversityCompletedMetabolic Syndrome | Hyper-LDL-cholesterolemiaUnited States
-
Supplement Formulators, Inc.TerminatedOxidized Low Density LipoproteinUnited States
-
Novartis PharmaceuticalsCompletedAtherosclerotic Cardiovascular Disease | Atherosclerotic Cardiovascular Disease Risk Equivelents | Elevated Low Density Lipoprotein CholesterolUnited Kingdom
-
Wake Forest University Health SciencesCompletedCardiovascular Diseases | Diabetes | Metabolic Syndrome | Liver Fat | Cardiovascular Risk Factor | Diet Habit | Dietary Modification | High Cholesterol | Triglycerides High | Low-density-lipoprotein-type | HDL Cholesterol, Low Serum | High Blood Sugar | Intra-abdominal Fat | High Density Lipoprotein DeficiencyUnited States
-
University of SydneyUniversity of Oslo; Imperial College London; Amgen; The Thrombolysis in Myocardial...TerminatedCardiovascular Diseases | Coronary Heart Disease | Cardiovascular Morbidity | Low-density-lipoprotein-typeUnited Kingdom, United States, Norway
-
University of HoustonAmerican Diabetes AssociationActive, not recruitingSedentary Lifestyle | Lipid Metabolism Disorders | Hyperinsulinemia | Aging Problems | Glucose Tolerance Impaired | Metabolic Disorder, Glucose | Low-density-lipoprotein-type | Inactivity, PhysicalUnited States